Efficacy and safety of adalimumab across subgroups of patients with moderate to severe psoriasis

Journal of the American Academy of Dermatology

Volumn 63, Issue 3, 2010, Pages 448-456

  Menter, Alan ^a   Gordon, Kenneth B ^b   Leonardi, Craig L ^c   Gu, Yihua ^d   Goldblum, Orin M ^d  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c Central Dermatology   (United States)

^d ABBOTT LABORATORIES   (United States)

Author keywords

Age; Body mass index; Body weight; Disease duration; Health related quality of life; Race; Symptom severity; Tumor necrosis factor antagonist

Indexed keywords

ADALIMUMAB; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CORTICOSTEROID; EFALIZUMAB; PLACEBO; PSORALEN; TOPICAL AGENT; MONOCLONAL ANTIBODY;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BODY MASS; BODY WEIGHT; CLINICAL TRIAL; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROSSOVER PROCEDURE; DEMYELINATING DISEASE; DEPRESSION; DIABETES MELLITUS; DISEASE DURATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; GROUPS BY AGE; HEMATOLOGIC DISEASE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INJECTION SITE REACTION; LIVER DISEASE; LUPUS LIKE SYNDROME; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTICENTER STUDY; OBESITY; OPPORTUNISTIC INFECTION; PHASE 3 CLINICAL TRIAL; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; PSORIASIS SEVERITY INDEX; RACE; RANDOMIZED CONTROLLED TRIAL; SEX; SIDE EFFECT; SKIN CANCER; TOPICAL TREATMENT; TREATMENT DURATION; ULTRAVIOLET A RADIATION; UNSPECIFIED SIDE EFFECT; UPPER RESPIRATORY TRACT INFECTION; ADOLESCENT; ADVERSE DRUG REACTION; ANALYSIS OF VARIANCE; CANADA; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; FOLLOW UP; MAXIMUM TOLERATED DOSE; MIDDLE AGED; MULTIVARIATE ANALYSIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UNITED STATES;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANTIBODIES, MONOCLONAL; CANADA; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG TOXICITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PSORIASIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UNITED STATES; ANTIBODIES, MONOCLONAL, HUMANIZED; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS;

EID: 77955924889     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2009.09.040     Document Type: Article

References (19)

1. T. Henseler, and E. Christophers Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris J Am Acad Dermatol 13 1985 450 456
2. S.K. Kurd, and J.M. Gelfand The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004 J Am Acad Dermatol 6 2009 218 224
3. R.S. Stern, T. Nijsten, S.R. Feldman, D.J. Margolis, and T. Rolstad Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction J Investig Dermatol Symp Proc 9 2004 136 139
4. G. Lomholt Environment and genetics in psoriasis Ann Clin Res 8 1976 290 297
5. F. Brandrup, N. Holm, N. Grunnet, K. Henningsen, and H.E. Hansen Psoriasis in monozygotic twins: variations in expression in individuals with identical genetic constitution Acta Derm Venereol 62 1982 229 236
6. R.P. Nair, P.E. Stuart, I. Nistor, R. Hiremagalore, N.V. Chia, and S. Jenisch Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene Am J Hum Genet 78 2006 827 851
7. A.B. Gottlieb, C. Chao, and F. Dann Psoriasis comorbidities J Dermatolog Treat 19 2008 5 21
8. D.M. Sommer, S. Jenisch, M. Suchan, E. Christophers, and M. Weichenthal Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis Arch Dermatol Res 298 2006 321 328
9. A.L. Neimann, D.B. Shin, X. Wang, D.J. Margolis, A.B. Troxel, and J.M. Gelfand Prevalence of cardiovascular risk factors in patients with psoriasis J Am Acad Dermatol 55 2006 829 835
10. D.D. Gladman, C. Antoni, P. Mease, D.O. Clegg, and P. Nash Psoriatic arthritis: epidemiology, clinical features, course, and outcome Ann Rheum Dis 64 Suppl 2005 ii14-7
11. A. Menter, S.K. Tyring, K. Gordon, A.B. Kimball, C.L. Leonardi, and R.G. Langley Adalimumab therapy for moderate to severe psoriasis: a randomized, controlled phase III trial J Am Acad Dermatol 58 2008 106 115
12. D.A. Revicki, M.K. Willian, A. Menter, K.B. Gordon, A.B. Kimball, and C.L. Leonardi Impact of adalimumab treatment on patient-reported outcomes: results from a phase III clinical trial in patients with moderate to severe plaque psoriasis J Dermatolog Treat 18 2007 341 350
13. D.M. Pariser, K.B. Gordon, K.A. Papp, C.L. Leonardi, P. Kwon, and P.G. Compton Clinical efficacy of efalizumab in patients with chronic plaque psoriasis: results from three randomized placebo-controlled phase III trials, part I J Cutan Med Surg 9 2005 303 312
14. K. Reich, A.B. Gottlieb, A. Kimball, and S. Li Consistency of infliximab response across subgroups of patients with psoriasis: integrated results from randomized controlled clinical trials [abstract] J Am Acad Dermatol 54 Suppl 2006 AB215
15. K. Gordon, N. Korman, E. Frankel, H. Wang, A. Jahreis, and R. Zitnik Efficacy of etanercept in an integrated multistudy database of patients with psoriasis J Am Acad Dermatol 54 Suppl 2006 S101 S111
16. L. Clark, and M. Lebwohl The effect of weight on the efficacy of biologic therapy in patients with psoriasis J Am Acad Dermatol 58 2008 443 446
17. W. Sterry, B.E. Strober, and A. Menter International Psoriasis Council. Obesity in psoriasis: the metabolic, clinical and therapeutic implications; report of an interdisciplinary conference and review Br J Dermatol 157 2007 649 655
18. W. Gulliver Long-term prognosis in patients with psoriasis Br J Dermatol 159 Suppl 2008 2 9
19. L. Naldi, A. Addis, S. Chimenti, A. Giannetti, M. Picardo, and C. Tomino Impact of body mass index and obesity on clinical response to systemic treatment for psoriasis: evidence from the PSOCARE project Dermatology 217 2008 365 373